DL-naproxen|Guanine|N(2),9-Diacetylguanine--Jiangsu BAJU Pharmaceutical CO., LTD.

PRODUCTS

In order to build high-quality products, the company spares no effort in technological innovation and investment in new product development.

work as a team learn as a child live as a whole

DL-naproxen

Guanine

N(2),9-Diacet

6-Hydroxy-2,4...

BDSI

6-Methoxy-2-A...

D-p-Methyl-su...

Jiangsu BaJu Pharmaceutical Co., Ltd. was established in Binhai by Zhejiang Charioteer Pharmaceutical Co., Ltd. in December, 2003. The company is professional in manufacturing of bulk medical intermediates

BRAND STRENGTH

18 years of accumulation, deep strength

Zhejiang Charioteer Pharmaceutical Co., Ltd. invested in Binhai Investment in December 2003

A modern enterprise integrating production, R&D and sales

Technical advantage

Quality is the soul, industry is the first, customer first

The company's products have formed technological advantages and production scales in China, and have certain popularity in the European and American markets.

The parent company has repeatedly passed the official GMP inspection and certification of the State Food and Drug Administration, the US FDA, the EU EDQM, the Brazilian ANVISA, the Korean KFDA, the Mexican Cofepris, etc., and its quality management system continues to cover the company and constantly improve.

Product strength

Strong production capacity, fast delivery

The company regards old product technology improvement, new product research and development, and technical cooperation as important measures for enterprise development.

Product safety and environmental protection, a sound quality assurance system, the company's research and development investment accounted for more than 5% of the annual sales revenue

Annual output value of more than 700 million yuan

Worry-free after-sale

Internal strength, sustainable development

The service team rooted in many years has established a nationwide market network and developed with customers.

The company has an excellent sales team and a capable technical service team. With the aim of “meeting the requirements of customers and related parties”, the company has strong market guarantee capability.

New starting point, new journey

Jiangsu BaJu Pharmaceutical Co., Ltd. located in the coastal industrial park of Jiangsu Binhai Economic Development Zone, is a wholly-owned subsidiary invested and built by Zhejiang Chetou Pharmaceutical Co., Ltd. in 2003. In 2013, the north area was expanded, with a registered capital of 250 million yuan, an area of about 400 mu, and a total number of more than 500 people. It is mainly engaged in the development, production and sales of series of raw materials and intermediates such as antiviral drugs, anti-inflammatory, antipyretic and analgesic drugs, anti-tumor drugs, cardiovascular drugs, etc. It is a provincial research center such as "National High tech Enterprise", "Jiangsu Key Enterprise Research and Development Institute", and "Jiangsu Anti cancer and Anti viral Drug Engineering Technology Research Center".

500 million yuan

With total assets of 500 million yuan

266800 square meters

Covers an area of 266800 Mu

500 people

More than 600 employees

250 million yuan

Registered capital of more than 200 million yuan

MORE >>

CULTURE

In future, our company will continuously increase investment in facilities upgrading, technology innovation, talent cultivation and culture development. We will serve all friends with more professional technique, products and service.